Business Wire

Armis Identifies Riskiest OT and ICS Devices Across Critical Infrastructure Industries

12.6.2023 15:00:00 EEST | Business Wire | Press release

Share

Armis, the leading asset visibility and security company, today released new research identifying the riskiest devices that pose threats to critical infrastructure industries: manufacturing, utilities and transportation. Data analyzed from the Armis Asset Intelligence and Security Platform, which tracks over three billion assets, found that the operational technology (OT) and industrial control systems (ICS) devices that present the highest risk to these industries are engineering workstations, SCADA servers, automation servers, historians and programmable logic controllers (PLCs).

Prioritization and vulnerability management remains an issue

Armis research found that engineering workstations are the OT device that received the most attempts of attack in the industry in the past two months, followed by SCADA servers. Fifty-six percent of engineering workstations have at least one unpatched critical severity Common Vulnerabilities and Exposures (CVEs) and 16% are susceptible to at least one weaponized CVE, published more than 18 months ago.

Uninterruptible Power Supplies (UPS) are the third device type that suffered the most attack attempts in the past two months. Although critical for continuity in an event of power outage, data showed that 60% of UPS devices have at least one unpatched critical severity CVE, which, as we saw with TLStorm, could potentially lead criminals to cause physical damage to the device itself or other assets connected to it.

Programmable Logic Controllers (PLCs) are another example, with 41% having at least one unpatched critical severity CVE. These legacy devices are of high importance as, if attacked, could lead to the disruption of central operations, but the research highlighted they can be susceptible to high risk factors such as end of support hardware and end of support firmware.

A set of additional devices represent risk to manufacturing, transportation and utilities environments as they have at least one weaponized CVE published before January 2022: 85% of barcode readers, 32% of industrial managed switches, 28% of IP cameras and 10% of printers.

OT industries are characterized by having multiple locations, multiple lines of production and complex distribution lines with a vast amount of both managed and unmanaged devices on their networks. In that context, understanding where risk comes from and remediation is needed presents a significant challenge and can be an obstacle to vulnerability management, posing an entry point for malicious actors.

“In an ICS environment it's pretty common to have vulnerable devices, so professionals need to see what assets are on their network and additional intelligence on what those devices are actually doing,” said Nadir Izrael CTO and Co-founder of Armis. “Contextual data will enable teams to define what risk each device poses to the OT environment so that they can prioritize remediation of critical and/or weaponized vulnerabilities to quickly reduce the attack surface.”

There is a need for collaboration between OT and IT teams

OT industries have significantly changed in the past years due to the convergence of OT and Information Technology (IT). This alignment is driving a new phase for the Industrial Era and will enable cross-domain collaboration but, in practice, unified management of both environments has yet to take place. With OT teams focused on maintaining industrial control systems, mitigating risks to OT and ensuring overall integrity within operational environments, more IT focused duties have been left aside.

Four out of the five riskiest devices notably run Windows operating systems, showcasing how a basic understanding of asset risk and securing vulnerable assets is still a challenge for IT and OT teams.

Armis looked at device types and found that many are more exposed to malicious activity because they are using the SMBv.1 protocol, end of support operating systems and many open ports. SMBv.1 is a legacy, unencrypted and complicated protocol with vulnerabilities that have been targeted in the infamous Wannacry and NotPetya attacks. Security experts previously advised organizations to stop using it completely, but the data shows it is still preeminent in the field.

“From an organizational perspective, having a risk-based approach to vulnerability management must go hand in hand with OT and IT departments working together to help coordinate mitigation efforts,” continued Izrael. “Cross-departmental projects will help streamline process and resource management and achieve greater compliance and data security. Overall, to navigate the challenges of the new industrial era, security professionals need an IT/OT convergence security solution that shields all assets connected to the network.”

The Armis Unified Asset Intelligence Platform discovers all connected assets, maps out the communications and relationships between them, and adds contextual intelligence to help understand their context and the risk they may introduce to the business. It is purpose-built to protect both OT and IT environments and can ingest meaningful signals from hundreds of IT and OT platforms. Armis’ cloud-based threat detection engine uses machine learning and artificial intelligence to detect when a device is operating outside of its normal “known good” baseline and triggers an automated response for an easier management of the overall attack surface.

Armis was recognized by ISG as an OT Security Leader for the 3rd consecutive year in the 2022 report “ISG Provider Manufacturing Security Services: OT Security Solutions”. And was named a Representative Vendor for the 3rd consecutive year in the Gartner “Market Guide for Operational Technology Security.”

To see how Armis stops threats and protects global organizations such as Colgate-Palmolive and Fortive, and helps utilities, transportation and leading manufacturers stay online 24/7, 365 days a year, please visit: https://www.armis.com

Methodology

Armis calculated device risk by looking at all devices on the Armis Asset Intelligence and Security Platform and identifying which types have the highest-severity risk factor and/or Common Vulnerabilities and Exposures (CVEs). Additionally, business impact level and endpoint protections had a weighted influence.

About Armis

Armis, the leading asset visibility and security company, provides the industry’s first unified asset intelligence platform designed to address the new extended attack surface that connected assets create. Fortune 100 companies trust our real-time and continuous protection to see with full context all managed, unmanaged assets across IT, cloud, IoT devices, medical devices (IoMT), operational technology (OT), industrial control systems (ICS), and 5G. Armis provides passive cyber asset management, risk management, and automated enforcement. Armis is a privately held company and headquartered in California.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Contacts:
Rebecca Cradick
Senior Director, Global Communications
Armis
pr@armis.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 15:00:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.

Fortegra Completes Acquisition by DB Insurance29.5.2026 23:30:00 EEST | Press release

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 23:01:00 EEST | Press release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release

NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release

Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye